JP2019533644A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019533644A5 JP2019533644A5 JP2019514312A JP2019514312A JP2019533644A5 JP 2019533644 A5 JP2019533644 A5 JP 2019533644A5 JP 2019514312 A JP2019514312 A JP 2019514312A JP 2019514312 A JP2019514312 A JP 2019514312A JP 2019533644 A5 JP2019533644 A5 JP 2019533644A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- combination
- permeation enhancer
- permeation
- sol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662394716P | 2016-09-14 | 2016-09-14 | |
| US62/394,716 | 2016-09-14 | ||
| PCT/US2017/051577 WO2018053140A1 (en) | 2016-09-14 | 2017-09-14 | Compositions with permeation enhancers for drug delivery |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019533644A JP2019533644A (ja) | 2019-11-21 |
| JP2019533644A5 true JP2019533644A5 (enExample) | 2020-11-05 |
| JP7277360B2 JP7277360B2 (ja) | 2023-05-18 |
Family
ID=61619716
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019514312A Active JP7277360B2 (ja) | 2016-09-14 | 2017-09-14 | 薬物送達のための透過促進剤を有する組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200138710A1 (enExample) |
| EP (1) | EP3512501A4 (enExample) |
| JP (1) | JP7277360B2 (enExample) |
| KR (1) | KR20190053215A (enExample) |
| CN (2) | CN109937033A (enExample) |
| AU (1) | AU2017326347B2 (enExample) |
| CA (1) | CA3036696A1 (enExample) |
| WO (1) | WO2018053140A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7046793B2 (ja) | 2015-08-05 | 2022-04-04 | ザ チルドレンズ メディカル センター コーポレーション | 薬物送達のための浸透促進剤を含む組成物 |
| US20230270749A1 (en) * | 2020-08-03 | 2023-08-31 | Children's Medical Center Corporation | Thermo-sensitive permeation enhancing formulations for drug delivery |
| GB202100945D0 (en) * | 2021-01-25 | 2021-03-10 | Brightcure Ltd | A composition useful for treating bacterial infections |
| DE202021106639U1 (de) | 2021-10-08 | 2023-01-10 | Maria Clementine Martin Klosterfrau Vertriebsgesellschaft mit beschränkter Haftung | Neue Therapiekonzepte für die Behandlung von Otitis |
| CN117618338A (zh) * | 2022-08-16 | 2024-03-01 | 海南普利制药股份有限公司 | 一种稳定的奥利万星药物水溶液及其制备方法 |
| CN118518439B (zh) * | 2023-02-17 | 2025-09-16 | 清华大学 | 离子液体制剂和组织处理方法及其应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1162148C (zh) * | 1994-08-30 | 2004-08-18 | 阿尔康实验室公司 | 含有纤维素醚的热凝胶药物转运载体 |
| US6316011B1 (en) * | 1998-08-04 | 2001-11-13 | Madash, Llc | End modified thermal responsive hydrogels |
| US6685917B2 (en) * | 2000-11-22 | 2004-02-03 | Rxkinetix, Inc. | Treatment of mucositis |
| US7220431B2 (en) * | 2002-11-27 | 2007-05-22 | Regents Of The University Of Minnesota | Methods and compositions for applying pharmacologic agents to the ear |
| US20070098772A1 (en) * | 2005-09-23 | 2007-05-03 | Westcott Tyler D | Transdermal norelgestromin delivery system |
| WO2009142719A2 (en) * | 2008-05-19 | 2009-11-26 | Massachusetts Institute Of Technology | Tympanic membrane permeating ear drops and uses thereof |
| CA2732686C (en) * | 2008-12-22 | 2017-10-03 | Otonomy, Inc. | Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| JP7046793B2 (ja) * | 2015-08-05 | 2022-04-04 | ザ チルドレンズ メディカル センター コーポレーション | 薬物送達のための浸透促進剤を含む組成物 |
-
2017
- 2017-09-14 CN CN201780069720.5A patent/CN109937033A/zh active Pending
- 2017-09-14 CA CA3036696A patent/CA3036696A1/en active Pending
- 2017-09-14 KR KR1020197010227A patent/KR20190053215A/ko not_active Withdrawn
- 2017-09-14 US US16/333,368 patent/US20200138710A1/en active Pending
- 2017-09-14 EP EP17851534.2A patent/EP3512501A4/en active Pending
- 2017-09-14 JP JP2019514312A patent/JP7277360B2/ja active Active
- 2017-09-14 AU AU2017326347A patent/AU2017326347B2/en active Active
- 2017-09-14 WO PCT/US2017/051577 patent/WO2018053140A1/en not_active Ceased
- 2017-09-14 CN CN202510689336.1A patent/CN120392650A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018522905A5 (enExample) | ||
| CN101137359B (zh) | 治疗耳感染的方法 | |
| JP2023523155A5 (enExample) | ||
| US12201622B2 (en) | Continuous delivery of lenalidomide and other immunomodulatory agents | |
| BRPI0608690A2 (pt) | uso de uma composição antimicrobiana | |
| EP3446692A1 (en) | Methods of preserving injectable pharmaceutical compositions comprising a cyclodextrin and a hydrophobic drug | |
| CN101588789B (zh) | 用于治疗牛和其它动物炎症的药物组合物和方法 | |
| JP2011173928A5 (enExample) | ||
| CN113853196B (zh) | 长效可注射调配物和其用途 | |
| US20250302966A1 (en) | Fulvestrant formulations | |
| JP2017031202A (ja) | 哺乳動物の内耳及び外耳の感染症の治療に有用な耳科用組成物 | |
| BR112019026073B1 (pt) | Formulações em gel de nu-3 e usos das mesmas | |
| JP2010195823A (ja) | 小動物用の注射可能な獣医用組成物 | |
| US20140348959A1 (en) | Formulations and Methods for Treating Ear Conditions | |
| US9511077B2 (en) | Medical devices and methods comprising an anabolic agent for wound healing | |
| US20140107088A1 (en) | Medical devices and methods comprising an anabolic agent for treatment of an injury | |
| PT1811995E (pt) | Composição veterinária transmucosa compreendendo detomidina | |
| CA2869377C (en) | Fulvestrant formulations | |
| US20200330436A1 (en) | Compositions and Methods for Treatment and Prevention of Pyrexia in Horses | |
| TWI649097B (zh) | 乙醯胺酚之可注射製劑 | |
| JP2005089345A (ja) | 虫刺され治療薬 | |
| WO2026041786A1 (en) | Injectable veterinary composition and uses thereof | |
| US20150141518A1 (en) | Water-miscible stable solution composition for pharmaceutically active ingredients that are poorly soluble in water and susceptible to chemical degradation | |
| JPWO2013125440A1 (ja) | 動物向け外皮用製剤 |